However, recent research demonstrated that increased markers of memory/antigen experience (CD45RA, CD27, and CD127) in the peripheral blood of PD-1+ T cells are found in glioblastoma patients, suggesting that the PD-1+ peripheral T cells of GBM patients exhibit activation functions compared to GBM TILs [25]. Here, CD27 is linked to glioblastoma.